AZATHIOPRINE VS MESALAMINE FOR PREVENTION OF POST-OPERATIVE CLINICAL RELAPSE IN CROHN'S DISEASE PATIENTS WITH SEVERE ENDOSCOPIC RECURRENCE: DATA ON EFFICACY AND SAFETY FROM AN IG-IBD MULTICENTER RANDOMIZED DOUBLE-BLIND DOUBLE-DUMMY TRIAL

被引：0

作者：

Orlando, A. ^{[1
]}

Mocciaro, F. ^{[2
]}

Ventimiglia, M. ^{[1
]}

Renna, S. ^{[1
]}

Scimeca, D. ^{[3
]}

Rispo, A. ^{[4
]}

Scribano, M. L. ^{[5
]}

Testa, A. ^{[4
]}

Aratari, A. ^{[6
]}

Bossa, F. ^{[7
]}

Angelucci, E. ^{[8
]}

Onali, S. ^{[9
]}

Cappello, M. ^{[10
]}

Giunta, M. ^{[3
]}

Castiglione, F. ^{[4
]}

Papi, C. ^{[6
]}

Annese, V. ^{[7
]}

Biancone, L. ^{[9
]}

Kohn, A. ^{[5
]}

Di Mitri, R. ^{[2
]}

Cottone, M. ^{[11
]}

机构：

[1] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy

[2] ARNAS Civ Di Cristina Benfratelli Hosp, Gastroenterol & Endoscopy Unit, Palermo, Italy

[3] Villa Sofia Cervello Hosp, Gastroenterol Unit, Palermo, Italy

[4] Univ Naples Federico II, Dept Gastroenterol, Naples, Italy

[5] San Camillo Forlanini, Gastroenterol Unit, Rome, Italy

[6] San Filippo Neri Hosp, Dept Gastroenterol, Rome, Italy

[7] Casa Sollievo Sofferenza Hosp, IRCCS, Dept Gastroenterol, San Giovanni Rotondo, FG, Italy

[8] Sapienza Univ, Dept Gastroenterol, Rome, Italy

[9] Tor Vergata Univ, Dept Gastroenterol, Rome, Italy

[10] Palermo Univ, Dept Gastroenterol, Palermo, Italy

[11] Villa Sofia Cervello Hosp, Internal Med, Palermo, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2019年 / 51卷

关键词：

D O I：

10.1016/S1590-8658(19)30473-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P.07.24

引用

页码：E232 / E232

页数：1

共 50 条

[31] Efficacy and Tolerability of a Generic and a Branded Formulation of Atorvastatin 20 mg/d in Hypercholesterolemic Korean Adults at High Risk for Cardiovascular Disease: A Multicenter, Prospective, Randomized, Double-Blind, Double-Dummy Clinical Trial
Kim, Sang-Hyun
Park, Kyungil
Hong, Soon-Joon
Cho, Young-Seok
Sung, Ji-Dong
Moon, Geon-Woong
Yoon, Myung-Ho
Lee, Moo-Yong
Hyon, Min-Su
Kim, Dong-Woon
Kim, Hyo-Soo
CLINICAL THERAPEUTICS, 2010, 32 (11) : 1896 - 1905
[32] Efficacy and safety of eplerenone Tablets in Chinese patients with mild to moderate essential hypertension: a randomized, multicenter, double-blind, double dummy,positive drug parallel-controlled clinical trial
Zhang, Yeping
Liu, Liwei
Li, Yishi
Huang, Yiling
Wang, Li
Pang, Huimin
Duan, Bing
Zhang, Yinfeng
Xu, Zhimin
CARDIOLOGY, 2011, 120 : 99 - 100
[33] Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial
Facheris, Maurizio
Robieson, Weining
Fisseha, Nahome
Standaert, David
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 331 - 331
[34] Comparative Clinical Trial of S-Adenosylmethionine Versus Nabumetone for the Treatment of Knee Osteoarthritis: An 8-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Phase IV Study in Korean Patients
Kim, Jinhyun
Lee, Eun Young
Koh, Eun-Mi
Cha, Hoon-Suk
Yoo, Bin
Lee, Chang Keun
Lee, Yunjong
Ryu, Heejung
Lee, Ki Hoon
Song, Yeong Wook
CLINICAL THERAPEUTICS, 2009, 31 (12) : 2860 - 2872
[35] Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients: Design of a Phase 3, Randomized, Double-Blind, Double-Dummy, Active Controlled 12-Week Trial
Facheris, Maurizio
Robieson, Weining
Fisseha, Nahome
Standaert, David
NEUROLOGY, 2021, 96 (15)
[36] Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
Farokhnia, Mehdi
Sabet, Mehdi Shafiee
Iranpour, Negar
Gougol, Amirhossein
Yekehtaz, Habibeh
Alimardani, Roozbeh
Farsad, Farzaneh
Kamalipour, Maryam
Akhondzadeh, Shahin
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (04) : 351 - 359
[37] Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs amlodipine for Stage-I primary hypertension- study protocol for a prospective Double-Dummy, Double-Blind, placebo-controlled Randomized Clinical Trial
Yadav, Babita
Rao, Bcs
Narang, Rajiv
Jameela, Sophia
Khanduri, Shruti
Sharma, Sakshi
Dinesh, Drishya
Srivastava, Arti
Bhardwaj, Richa
Gupta, Bharti
Srikanth, N.
Arya, Dharamvir Singh
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2025, 25 (01)
[38] NOVEL MICROSCOPIC COLITIS DISEASE ACTIVITY INDEX REFLECTS HIGH EFFICACY OF ORAL ONCE DAILY BUDESONIDE TREATMENT IN LYMPHOCYTIC COLITIS: POST-HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER, TRIAL
Miehlke, Stephan
Emese-Mihaly, Daniela Aust
Amerding, Peter
Boehm, Guenter
Bonderup, Ole
Fernandez-Banares, Fernando
Kupcinskas, Juozas
Kristian, Lars
Rehbehn, Munck Kai-Uwe
Nacak, Tanju
Greinwald, Roland
Munch, Andreas
GASTROENTEROLOGY, 2018, 154 (06) : S384 - S384
[39] A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
Assaad-Khalil, Samir
Elkafrawy, Nabil
Khaled, Mohsen
Mogeib, Omneya
Badr, Hytham
Rashwan, Ahmed
Youssef, Mahmoud
Eltamawy, Khaled
Mohamed, Shahnaz
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[40] One Year Data from the Sonic Study: A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab Plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy
Sandborn, William J.
Rutgeerts, Paul J.
Reinisch, Walter
Mantzaris, Gerassimos J.
Kornbluth, Asher
Rachmilewitz, Daniel
Lichtiger, Simon
D'Haens, Geert R.
van der woude, Christien J.
Diamond, Robert
Broussard, Delma
Tang, Kezhen L.
Colombel, Jean-Frederic
GASTROENTEROLOGY, 2009, 136 (05) : A116 - A116

← 1 2 3 4 5 →